On Friday, in the course of current trade, Shares of Southwest Airlines Co. (NYSE:LUV), dropped -0.48%, and is now trading at $37.05.
Southwest Airlines, declared new nonstop service from Ronald Reagan Washington National Airport (DCA) to Orlando, Florida starting on Nov. 1. Orlando will be Southwest’s third Florida destination from DCA, where it is the second largest carrier as measured by passengers carried. Southwest will now offer flights to 17 nonstop destinations from this convenient downtown airport.
Southwest Airlines operates more than 260 daily nonstop flights from its three Washington, D.C. area airports. Since July of last year, the airline has added seven new international destinations from Baltimore/Washington Thurgood Marshall International airport, and new nonstop service from Washington, D.C. (Reagan National) to Chicago (Midway), Columbus, Dallas Love Field, Indianapolis, Nashville, New Orleans, Tampa Bay, Ft. Lauderdale/Hollywood starting on August 9, and Orlando starting in November 2015. In addition, the carrier’s long-haul offerings from Washington Dulles have grown in the past year to add both Las Vegas, and San Diego as nonstop routes.
Southwest Airlines Co. operates passenger airlines that provide planned air transportation services in the United States and near-international markets. As of December 31, 2014, it operated 665 Boeing 737 aircraft; and had 12 Boeing 717 aircraft.
During an Afternoon trade, Shares of Baxter International Inc. (NYSE:BAX), dipped -0.13%, and is now trading at $67.45.
Baxter International, declared that its BioScience business has presented a marketing authorization application (MAA) to 17 competent authorities in Europe following the decentralized procedure (DCP) for approval of its investigational 20 percent concentration subcutaneous immune globulin (IGSC) treatment for primary immunodeficiencies (PI, a group of disorders in which part of the body’s immune system is missing or does not function properly). Baxter is advancing the 20 percent treatment as part of its efforts to expand the primary immunodeficiency treatment portfolio to address patient needs.
The filing is based on the positive results of a Phase 2/3 study that evaluated the efficacy, safety, tolerability and pharmacokinetics (PK) of IGSC 20 percent in European patients at least two years old with PI. The study met its primary endpoint that measured the rate of validated acute serious bacterial infections (VASBIs); these results were initially presented during the 2014 biennial congress of the European Society for Immunodeficiencies (ESID).
In the study, only one event of VASBI was stated during treatment with IGSC 20 percent, which equated to a low rate of 0.022/patient-year contrast with the specified threshold of one VASBI/patient-year (P<0.0001). Importantly, nearly all infusions (99.8%) were accomplished without any interruption, slowing, or stopping the infusion. The rate of local adverse events (AEs) considered related to IGSC 20 percent treatment was 0.052/affected infusion (in 17 of 48 patients). The majority (99.8%) of local AEs were mild in severity and the most common events were erythema, swelling, pruritus, and pain/discomfort.
Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.
Shares of International Business Machines Corporation (NYSE:IBM), during its Friday’s current trading session fell -0.51%, and is now trading at $172.46.
Scientists from IBM Research, the University of Melbourne and the University of Queensland have moved a step closer to identifying the nanostructure of cellulose – the basic structural component of plant cell walls.
Tapping into the IBM Blue Gene/Q supercomputer at the Victorian Life Sciences Computation Initiative (VLSCI), researchers have been able to model the structure and dynamics of cellulose at the molecular level. The insights could pave the way for more disease resistant varieties of crops and enhance the sustainability of the pulp, paper and fibre industry – one of the main users of cellulose.
The work, which was described in a recent scientific paper published in Plant Physiology, represents a noteworthy step towards our understanding of cellulose biosynthesis and how plant cell walls assemble and function. The research is part of a longer-term program to develop a 3D computer simulated model of the entire plant wall. Globally, IBM is a leader in the field of computational biology - the interface of information technology and biology through which scientists are exploring ways to improve crop yields, enhance food traceability and secure supply chains.
Using the IBM Blue Gene/Q supercomputer at VLSCI known as Avoca, scientists were able to perform the quadrillions of calculations required to model the motions of cellulose atoms. The research shows that within the cellulose structure, there are between 18 and 24 chains present within an elementary microfibril, much less than the 36 chains that had formerly been assumed.
International Business Machines Corporation provides information technology (IT) products and services worldwide. The company’s Global Technology Services segment provides IT infrastructure and business process services, such as outsourcing, processing, integrated technology, cloud, and technology support.
Finally, CBS Corporation (NYSE:CBS), lost -0.06% Friday.
CBS Corporation, declared that it will report results for the second quarter of 2015 after the market closes on Wednesday, August 5, 2015.
The Company will then conduct a teleconference call at 4:30 PM, ET. The call is open to the general public. The domestic conference call number is (800) 776-9057. Please call at least five minutes in advance to ensure that you are connected preceding to the presentation. The international dial-in number is (913) 312-4373.
CBS Corporation operates as a mass media company worldwide. It operates through four segments: Entertainment, Cable Networks, Publishing, and Local Broadcasting. The Entertainment segment distributes a plan of news and public affairs broadcasts, and sports and entertainment programming; produces, acquires, and distributes programming, counting series, specials, news, and public affairs; operates online content networks for information and entertainment; and produces, acquires, and distributes theatrical motion pictures.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
